Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics 07/01/14 Boston
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch 05/20/14 Texas
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
Forma Gets $225M More, And a Potential Buyout, From Celgene 04/01/14 Boston
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge 03/31/14 Boston
Genentech Joins “What’s Hot in Cancer Immunotherapy” Apr. 22 03/07/14 Seattle
Merck Joins ‘What’s Hot in Cancer Immunotherapy’ Apr. 22 03/04/14 Seattle
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
RidePal and the Private Bus Wars: Q&A with Founder Nathalie Criou 12/18/13 San Francisco
Gates Foundation Gets UCSF Chief Desmond-Hellmann as New CEO 12/17/13 Seattle
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Building Biotechs to Last: The Photos 12/12/13 San Francisco
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Page 1 of 15 next page »